Immunology

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

Vaccine to treat lung cancer

A first-of-its-kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

July: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Could bacteriophages replace antibiotics?

A small-scale preliminary trial concludes that bacteriophages could be a viable replacement for antibiotics in the future.

Antibiotic resistance and microwaves

Lecturer in Molecular Microbiology Tina Joshi looks at the detection of antimicrobial-resistant bacteria in the timeframe of a doctor’s appointment.

New delivery method for immunotherapy combination

Using nanoparticles to bind molecules that can unleash and stimulate immune cells, US researchers found they could more effectively trigger the body’s defence systems against cancer in laboratory studies.

24/7 laboratory service

With round-the-clock working becoming the norm in the NHS, Training Officer Chika K Eze looks at its potential impact for pathology departments.

Preventing allergic reactions

Researchers have discovered a new mechanism in which an antibody can prevent allergic reactions in a broad range of patients.

No antibiotics for sore throats

Doctors should not prescribe antibiotics for most people with sore throats, say new guidelines. While most sore throats are caused by viral infections, research suggests antibiotics are prescribed in 60% of cases.

The enzyme that defines colon cancer

Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells. It appears to drive the conversion of normal tissue into cancer by attaching sugar molecules, or glycans, to proteins in the cell.

Top